| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 357-08-4 | 鹽酸納洛酮; 17-烯丙基-4,5a-環(huán)氧基-3,14-二羥基嗎啡喃-6-酮鹽酸鹽 | Naloxone hydrochloride; 4,5alpha-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one hydrochloride | ![]() | C19H21NO4.HCl;C19H22ClNO4 | 詳情 | 供應商 |
| 16676-29-2 | 鹽酸納曲酮; 17-環(huán)丙基甲基-4,5-環(huán)氧-3,14-二羥基嗎啡喃-6-酮鹽酸鹽 | Naltrexone hydrochloride; (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride | ![]() | C20H23NO4.HCl | 詳情 | 供應商 |
| 51481-60-8 | 二水合鹽酸納洛酮; 17-烯丙基-4,5a-環(huán)氧基-3,14-二羥基嗎啡喃-6-酮鹽酸鹽二水合物 | Naloxone hydrochloride dihydrate; 4,5alpha-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one hydrochloride dihydrate | ![]() | C19H21NO4.HCl.2(H2O) | 詳情 | 供應商 |
| 10024-89-2 | 嗎啡啉鹽酸鹽 | morpholine, hydrochloride; morpholine hydrochloride | ![]() | C4H10ClNO | 詳情 | 供應商 |
| 41035-30-7 | (S)-(+)-阿樸嗎啡鹽酸鹽水合物 | 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aS)-; 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (S)- (9CI); (6aS)-10,11-Dihydroxyaporphine hydrochloride; (S)-(+)-Apomorphinehydrochloride; (S)-Apomorphine hydrochloride | ![]() | C17H18ClNO2 | 詳情 | 供應商 |
| 314-19-2 | R-(-)-阿樸嗎啡鹽酸鹽; 阿撲嗎啡; 鹽酸去水嗎啡; 煙酸阿樸嗎啡; 鹽酸阿樸嗎啡; 變嗎啡鹼鹽酸鹽 | 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aR)-; 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)- (9CI); 4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-,hydrochloride, (R)-; 6ab-Aporphine-10,11-diol, hydrochloride (8CI); (-)-Apomorphine hydrochloride; Apomorphine hydrochloride; Apomorphinium chloride; NSC 11442; R-(-)-Apomorphinehydrochloride; Uprima | ![]() | C17H17NO2.ClH | 詳情 | 供應商 |
| 72786-10-8 | (E)-4-[[(5Α,6Β)-17-(環(huán)丙基甲基)-4,5-環(huán)氧-3,14-二羥基嗎啡-6-基]氨基]-4-氧-2-丁烯酸甲酯鹽酸鹽 | BETA-FUNALTREXAMINE HYDROCHLORIDE; (E)-[4-[[(5A,6B)-17-CYCLOPROPYLMETHYL]-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOICACID METHYL ESTER HYDROCHLORIDE; (E)-4-[[(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOIC ACID METHYL ESTER HYDROCHLORIDE; BETA-FUNALTREXAMINE; BETA-FUNALTREXAMINE HYDROCHLORIDE; BETA-FNA HYDROCHLORIDE; B-FUNALTREXAMINE HYDROCHLORIDE (B-FNA) S PECIFIC NON-EQUILIBR; BETA-FUNALTREXAMINE HCL; (E)-4-((5a,6b)-17-Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)amino)-4-oxo-2-butenoicacidmethylesterhyd | ![]() | C25H32ClN2O6 | 詳情 | 供應商 |
| 558442-97-0 | 反式-1-氨基-4-(嗎啡啉-4-基)-環(huán)己烷鹽酸鹽 | CyclohexanaMine | 無 | 詳情 | 供應商 |